Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
Postdoctoral Station of Clinical Medicine of Anhui Medical University, Hefei, Anhui, China.
Arthritis Res Ther. 2022 Jan 31;24(1):35. doi: 10.1186/s13075-022-02727-8.
Rheumatoid arthritis is a chronic systemic autoimmune disease characterized by synovial hyperplasia, inflammatory cell infiltration, and proliferation of inflammatory tissue (angiogranuloma). The destruction of joints and surrounding tissues eventually causes joint deformities and dysfunction or even loss. The S100 protein family is one of the biggest subtribes in the calcium-binding protein family and has more than 20 members. The overexpression of most S100 proteins in rheumatoid arthritis is closely related to its pathogenesis. This paper reviews the relationship between S100 proteins and the occurrence and development of rheumatoid arthritis. It will provide insights into the development of new clinical diagnostic markers and therapeutic targets for rheumatoid arthritis.
类风湿关节炎是一种慢性系统性自身免疫性疾病,其特征为滑膜增生、炎症细胞浸润和炎症组织(血管肉芽瘤)增殖。关节及其周围组织的破坏最终导致关节畸形和功能障碍,甚至丧失。S100 蛋白家族是钙结合蛋白家族中最大的亚族之一,拥有 20 多个成员。类风湿关节炎中大多数 S100 蛋白的过度表达与其发病机制密切相关。本文综述了 S100 蛋白与类风湿关节炎发生发展的关系,为类风湿关节炎新的临床诊断标志物和治疗靶点的开发提供思路。